<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref37" class="ref">
 <label class="label">37</label>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Chen</surname>
    <given-names class="given-names">YF</given-names>
   </name>
   <name class="name">
    <surname class="surname">Wang</surname>
    <given-names class="given-names">YW</given-names>
   </name>
   <name class="name">
    <surname class="surname">Huang</surname>
    <given-names class="given-names">WS</given-names>
   </name>
   <name class="name">
    <surname class="surname">Lee</surname>
    <given-names class="given-names">MM</given-names>
   </name>
   <name class="name">
    <surname class="surname">Wood</surname>
    <given-names class="given-names">WG</given-names>
   </name>
   <name class="name">
    <surname class="surname">Leung</surname>
    <given-names class="given-names">YM</given-names>
   </name>
   <etal class="etal"/>
  </person-group>
  <article-title class="article-title">Trans-cinnamaldehyde, an essential oil in cinnamon powder, ameliorates cerebral ischemia-induced brain injury via inhibition of neuroinflammation through attenuation of iNOS, COX-2 expression and NFkappa-B signaling pathway</article-title>
  <source class="source">Neuromol Med</source>
  <year class="year">2016</year>
  <volume class="volume">18</volume>
  <fpage class="fpage">322</fpage>
  <lpage class="lpage">333</lpage>
 </element-citation>
</ref>
